Search
Displaying 1 result
Perampanel
go.drugbank.com/drugs/DB08883
ApprovedInvestigational
Perampanel is a noncompetitive AMPA glutamate receptor antagonist. It is marketed under the name Fycompa™ and is indicated as an adjunct in patients over 12 years old for the treatment of partial-onset seizures that may or may not occur with generalized seizures. The FDA label includes an important black-boxed warni...